Novel recombinant BCG coexpressing Ag85B, ESAT-6 and mouse TNF-α induces significantly enhanced cellular immune and antibody responses in C57BL/6 mice

Microbiology and Immunology

Volumn 54, Issue 8, 2010, Pages 435-441

  Shen, Hongbo ^a   Wang, Chao ^a   Yang, Enzhuo ^a   Xu, Ying ^a   Liu, Wei ^a   Yan, Jingran ^a   Wang, Feifei ^a   Wang, Honghai ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Antibody response; Cellular immune response; Mouse TNF ; Recombinant BCG

Indexed keywords

BCG VACCINE; RECOMBINANT BCG ANTIGEN 85B EARLY SECRETORY ANTIGENIC TARGET 6 TUMOR NECROSIS FACTOR ALPHA FUSION PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; ACYLTRANSFERASE; ANTIGEN 85B, MYCOBACTERIUM TUBERCULOSIS; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; HYBRID PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BCG VACCINATION; C57BL 6 MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FUSION GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ANIMAL; ANTIBODY PRODUCTION; C57BL MOUSE; GENETICS; HUMAN; IMMUNOLOGY; TUBERCULOSIS;

ACYLTRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; FEMALE; GENE EXPRESSION; HUMANS; IMMUNITY, CELLULAR; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT FUSION PROTEINS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954983653     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2010.00232.x     Document Type: Article

References (21)

1. WHO report 2009 (2009)- Global tuberculosis control.
2. Gandhi N.R., Moll A., Sturm A.W., Pawinski R., Govender T., Lalloo U., Zeller K., Andrews J., Friedland G. (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368: 1575-1580.
3. Fine P. (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339-1345.
4. Nor N.M., Musab M. (2004) Approaches towards the development of a vaccine against tuberculosis: recombinant BCG and DNA vaccine. Tuberculosis 84: 102-109.
5. Xu Y., Zhu B., Wang Q., Chen J., Qie Y., Wang J., Wang H., Wang B., Wang H. (2007) Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice. FEMS Immunol Med Microbiol 51: 480-487.
6. Horwitz M.A., Harth Gn., Dillon B.J., Maslesa-Galic Sa. (2000) Recombinant bacillus Calmette-Guérin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 97: 13853-13858.
7. Pym A.S., Brodin P., Majlessi L., Brosch R., Demangel C., Williams A., Griffiths K.E., Marchal G., Leclerc C., Cole S.T. (2003) Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9: 533-539.
8. Daniel F.H., Azra B., Getahun A., Willem A.H., Gilla K., Jorge H.S., Frank W., Larry G., Jerald C.S., Marcus A.H. (2008) A new recombinant bacilli Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis 198: 1491-1501.
9. Gao H., Yue Y., Hu L., Xu W., Xiong S. (2009) A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge. Vaccine 27: 5313-5319.
10. Olsen A.W., Pinxteren L.A.H.V., Okkels L.M., Rasmussen P.B., Andersen P. (2001) Protection of mice with a tuberculosis subunit vaccine based on a fusion protein ofantigen 85B and ESAT-6. Infect Immun 69: 2773-2778.
11. Langermansa J.A.M., Dohertyb T.M., Vervennea R.A.W., Laanc Tvd., Lyashchenkod K., Greenwaldd R., Aggerb E.M., Aagaardb C., Horst Weilere, Soolingenc Dv. (2005) Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 23: 2740-2750.
12. Jacobs M., Togbe D., Fremond C., Samarina A., Allie N., Botha T., Carlos D., Parida S.K., Grivennikov S., Nedospasov S. (2007) Tumornecrosisfactoriscriticaltocontroltuberculosisinfection. Microbes Infect 9: 623-628.
13. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J., Schrelber R., Mak T.W., Bloom B.R. (1995) Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2: 561-572.
14. Flesch E.A., Kaufmann S.H.E. (1990) Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect Immu 58: 2675-2677.
15. Roach D.R., Briscoe H., Baumgart K., Rathjen D.A., Britton W.J. (1999) Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo. Infect Immun 67: 5473-5476.
16. Bruns H., Meinken C., Schauenberg P., Harter G., Kern P., Modlin R.L., Antoni C., Stenger. (2009) Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest 119: 1167-1177.
17. Stover C.K., Cruz V.F., Fuerst T.R. (1991) New use of BCG for recombinant vaccines. Nature 351: 456-460.
18. Martin R.M., Lew A.M. (1998) Is IgG2a a good Thl marker in mice? Immunology Today 19: 49.
19. Orme I.M. (1988) Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun 56: 3310-3312.
20. Shi C-h., Wang X-w., Zhang H., Zhang T-f., Wang L-m., Xu Z-k. (2008) Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis. DNA Cell Biol 27: 199-207.
21. Rodrigues M.F., Barsante M.M., Alves C.C.S., Souza M.A., Ferreira A.P., Amarante-Mendes G.P., Teixeira H.C. (2009) Apoptosis of macrophages during pulmonary Mycobacterium bovis infection: correlation with intracellular bacillary load and cytokine levels. Immunology 128: e691-e699.